modeling sars-cov-2 infection and novel therapeutic targets at barrier sites: wilfried posch, mui
Published 2 years ago • 79 plays • Length 23:49Download video MP4
Download video MP3
Similar videos
-
1:05:03
alan s perelson - modeling the within host dynamics of sars-cov-2 infection
-
59:17
sars-cov-2 community transmission during sip in san francisco-the unidos en salud test-to-care model
-
37:53
efforts by the ots community to combat sars-cov-2 and covid-19
-
59:35
3-11-21 - impact of sars-cov-2 spike protein variation on therapeutics and vaccines
-
56:31
animal models and methods for studying covid-19: golden hamsters and aerosolized sars-cov-2 delivery
-
2:05
porous peek - product animation
-
6:40
a new drug target in the fight against covid-19
-
33:28
sars-2 coronavirus (sars-cov-2) / novel coronavirus - part 1 features - covid-19
-
50:38
mechanistic modelling of sars-cov-2 immune memory, vaccines and variants | jamie cohen (idm)
-
4:29
building the sars-cov-2 model
-
47:00
point-of-care diagnostic of sars-cov-2: a systematic review and meta-analysis of real-world data
-
18:38
toru okamoto: development of an engineered ace2 decoy for the treatment of covid-19
-
23:56
structure-guided design of sars-cov-2 antivirals
-
57:37
structure-guided design of sars-cov-2 subunit vaccines | david veesler, phd
-
26:43
dr. wobus provides a 30 minute introduction to sars-cov-2
-
1:13:38
sars-cov-2 / covid-19 in usa and beyond (january 27, 2021)
-
25:47
2021 user workshop – 2.5 – pepmatch: homology of sars-cov-2 spike sequences to myocarditis antigens
-
2:00
sars-cov-2 spike mutation explorer app demonstration | medical visualisation with sarah iannucci
-
5:29
a blueprint to control the sars-cov-2 pandemic
-
10:48
uncovering genomic evidence of sars-cov-2 infection and reinfection
-
![humanized mouse models to study infections such as sars-cov-2 and their treatments [r. sedláček]](https://i.ytimg.com/vi/HtsUdXKV1sY/mqdefault.jpg)
29:13
humanized mouse models to study infections such as sars-cov-2 and their treatments [r. sedláček]
-
1:00
structure of sars-cov-2 main protease as a basis for drug design